ArticleCureus2025

Evaluation of Polmacoxib 2 mg for the Management of Hip and Knee Osteoarthritis: A Prospective, Single-Arm, Multicenter, Open-Label Study.

Rakesh Verma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.